Epinastine + Pseudoephedrine SR (Slow Release) Versus Epinastine Alone in Patients With Perennial Allergic Rhinitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate the clinical efficacy and safety of Epinastine 10 mg +
Pseudoephedrine 120 mg slow release (SR) administered twice a day, compared to Epinastine 10
mg alone administered twice daily.